Search by Drug Name or NDC
NDC 70954-0159-20 Clorazepate Dipotassium 3.75 mg/1 Details
Clorazepate Dipotassium 3.75 mg/1
Clorazepate Dipotassium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is CLORAZEPATE DIPOTASSIUM.
Product Information
| NDC | 70954-0159 |
|---|---|
| Product ID | 70954-159_23835ed6-9802-4fb5-88ef-bef2655db16c |
| Associated GPIs | 57100030100305 |
| GCN Sequence Number | 003745 |
| GCN Sequence Number Description | clorazepate dipotassium TABLET 3.75 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14092 |
| HICL Sequence Number | 001612 |
| HICL Sequence Number Description | CLORAZEPATE DIPOTASSIUM |
| Brand/Generic | Generic |
| Proprietary Name | Clorazepate Dipotassium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clorazepate Dipotassium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 3.75 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA213730 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70954-0159-20 (70954015920)
| NDC Package Code | 70954-159-20 |
|---|---|
| Billing NDC | 70954015920 |
| Package | 500 TABLET in 1 BOTTLE (70954-159-20) |
| Marketing Start Date | 2022-07-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |